United Therapeutics Financials

Values in thousands	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Revenue	$799,500	$798,600	$794,400	$735,900
Gross Profit	698,600	711,000	701,900	660,000
EBITDA	462,900	436,800	382,800	424,100
EBIT	441,000	415,700	417,400	404,400
Net Income	338,700	309,500	322,200	301,300
Net Change In Cash	799,500	798,600	794,400	735,900
Free Cash Flow	351,600	129,500	386,300	254,500
Cash	1,136,600	1,593,100	1,899,900	1,697,200
Basic Shares	47,300	48,300	48,600	48,700

Values in thousands	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue	$2,877,400	$2,327,500	$1,936,300	$1,685,500
Gross Profit	2,567,700	2,070,000	1,789,600	1,563,000
EBITDA	1,654,400	1,386,800	1,040,300	736,800
EBIT	1,581,900	1,333,600	989,000	686,900
Net Income	1,195,100	984,800	727,300	475,800
Net Change In Cash	2,877,400	2,327,500	1,936,300	1,685,500
Cost of Revenue			66,400	156,100
Free Cash Flow	1,080,600	747,600	663,700	477,400
Cash	1,697,200	1,207,700	961,200	894,800
Basic Shares	48,500	49,700	48,500	47,300